Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bukowski

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Cancer|October 8, 1997
Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2R M Bukowski
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Current approaches in cytoprotection: the role of amifostine (Ethyol) in altering and ameliorating toxicities in cancer therapyR M Bukowski
Progress in Hemostasis and Thrombosis|January 1, 1982
Thrombotic thrombocytopenic purpura: a reviewR M Bukowski
The Urologic Clinics of North America|February 1, 1993
Management of advanced and extragonadal germ-cell tumorsR M Bukowski
Seminars in Oncology|April 18, 2000
Cytokine combinations: therapeutic use in patients with advanced renal cell carcinomaR M Bukowski
International Journal of Colorectal Disease|June 1, 1987
Clinical trials in colorectal cancer: experience of the Gastrointestinal Tumor Study Group and the Southwest Oncology GroupR M Bukowski
Cancer Investigation|August 6, 1999
Chemoimmunotherapy of metastatic renal cell carcinomaR M Bukowski
Seminars in Urologic Oncology|May 17, 2001
Cytokine therapy for metastatic renal cell carcinomaR M Bukowski
Current Oncology Reports|December 21, 2000
Novel antineoplastic agentsR M Bukowski
Seminars in Oncology|August 1, 1994
Biologic therapy in patients receiving salvage treatmentR M Bukowski
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Cancer|October 8, 1997
Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2R M Bukowski
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Current approaches in cytoprotection: the role of amifostine (Ethyol) in altering and ameliorating toxicities in cancer therapyR M Bukowski
Progress in Hemostasis and Thrombosis|January 1, 1982
Thrombotic thrombocytopenic purpura: a reviewR M Bukowski
The Urologic Clinics of North America|February 1, 1993
Management of advanced and extragonadal germ-cell tumorsR M Bukowski
Seminars in Oncology|April 18, 2000
Cytokine combinations: therapeutic use in patients with advanced renal cell carcinomaR M Bukowski
International Journal of Colorectal Disease|June 1, 1987
Clinical trials in colorectal cancer: experience of the Gastrointestinal Tumor Study Group and the Southwest Oncology GroupR M Bukowski
Cancer Investigation|August 6, 1999
Chemoimmunotherapy of metastatic renal cell carcinomaR M Bukowski
Seminars in Urologic Oncology|May 17, 2001
Cytokine therapy for metastatic renal cell carcinomaR M Bukowski
Current Oncology Reports|December 21, 2000
Novel antineoplastic agentsR M Bukowski
Seminars in Oncology|August 1, 1994
Biologic therapy in patients receiving salvage treatmentR M Bukowski
Pageof 17